Form 8-K - Current report:
SEC Accession No. 0001823239-24-000028
Filing Date
2024-02-22
Accepted
2024-02-22 16:08:47
Documents
15
Period of Report
2024-02-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrvi-20240222.htm   iXBRL 8-K 30583
2 EX-99.1 exhibit991-q42023.htm EX-99.1 216835
  Complete submission text file 0001823239-24-000028.txt   397190

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrvi-20240222.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrvi-20240222_lab.xml EX-101.LAB 24851
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrvi-20240222_pre.xml EX-101.PRE 13046
16 EXTRACTED XBRL INSTANCE DOCUMENT mrvi-20240222_htm.xml XML 2833
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39725 | Film No.: 24664770
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)